Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites

Mette Agerbæk, Sara Bang-Christensen, Ali Salanti*

*Corresponding author for this work
5 Citations (Scopus)

Abstract

Malaria research has led to the discovery of oncofetal chondroitin sulfate, which appears to be shared between placental trophoblasts and cancer cells and can be detected by the evolutionary refined malaria protein VAR2CSA. Interestingly, using recombinant VAR2CSA to target oncofetal chondroitin sulfate shows promise for novel cancer diagnostics and therapeutics.

Original languageEnglish
JournalTrends in Parasitology
Volume35
Issue number3
Pages (from-to)178-181
ISSN1471-4922
DOIs
Publication statusPublished - Mar 2019

Keywords

  • cancer
  • oncofetal chondroitin sulfate
  • placental malaria
  • VAR2CSA

Fingerprint

Dive into the research topics of 'Fighting cancer using an oncofetal glycosaminoglycan-binding protein from malaria parasites'. Together they form a unique fingerprint.

Cite this